Jenny Mjösberg
Professor
E-postadress: jenny.mjosberg@ki.se
Telefon: +46852482917
Mobiltelefon: +46705472956
Besöksadress: Alfred Nobels allé 8, plan 7, 14152 Huddinge
Postadress: H7 Medicin, Huddinge, H7 CIM Mjösberg, 171 77 Stockholm
Om mig
- Jenny Mjösberg är professor i vävnadsimmunologi vid institutionen för medicin, Huddinge sedan 1 juli 2022.
Hon studerade biomedicinsk kemi vid Högskolan i Kalmar med examen 2003, och disputerade i klinisk immunologi vid Linköpings universitet 2010. Hon gjorde postdoc vid University of Amsterdam, Nederländerna, 2010–2012 och kom därefter till KI, inledningsvis som postdoc. 2014 blev hon ledare för en egen forskargrupp. Åren 2016–2019 var hon även engagerad som föreläsare vid Linköpings universitet på 20 procent.
Jenny Mjösberg blev docent 2019. Hon har bland annat tilldelats Vetenskapsrådets Consolidator Grant 2019, ERC Starting Grant 2020 och KI:s Consolidator Grant 2022.
Artiklar
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2025;122(6):e2414230122Boulouis C; Mouchtaridi E; Muller TR; Mak JYW; Fairlie DP; Bergman P; Michaelsson J; Halfvarson J; Mjosberg J; Buggert M; Sandberg JK
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2025;55(2):e202451150Rodahl IE; Ivarsson MA; Loh L; Mold JE; Westgren M; Friberg D; Mjosberg J; Bjorkstrom NK; Marquardt N; Nixon DF; Michaelsson J
- Article: GENES AND IMMUNITY. 2025;26(1):70-74Strunz B; Momayyezi P; Bilev E; Muvva JR; Chen P; Bister J; Schaffer M; Akber M; Cornillet M; Horowitz A; Malmberg K-J; Rooyackers O; Aleman S; Ljunggren H-G; Bjorkstrom NK; Stralin K; Hammer Q
- Article: SCIENCE IMMUNOLOGY. 2024;9(99):eadn2362Kammann T; Cai C; Sekine T; Mouchtaridi E; Boulouis C; Nilsen V; Ballesteros OR; Mueller TR; Gao Y; Raineri EJM; Mily A; Adamo S; Constantz C; Niessl J; Weigel W; Kokkinou E; Stamper C; Marchalot A; Bassett J; Ferreira S; Rodahl I; Wild N; Brownlie D; Tibbitt C; Mak JYW; Fairlie DP; Leeansyah E; Michaelsson J; Marquardt N; Mjosberg J; Jorns C; Buggert M; Sandberg JK
- Article: JOURNAL OF INFECTIOUS DISEASES. 2024;230(2):e318-e326Strunz B; Maucourant C; Mehta A; Wan H; Du L; Sun D; Chen P; Nordlander A; Gao Y; Cornillet M; Bister J; Kvedaraite E; Christ W; Klingstrom J; Geanon D; Parke A; Ekwall-Larson A; Rivino L; MacAry PA; Aleman S; Buggert M; Ljunggren H-G; Pan-Hammarstrom Q; Lund-Johansen F; Stralin K; Bjorkstrom NK
- Article: PLOS PATHOGENS. 2024;20(7):e1012390Garcia M; Garcia AC; Weigel W; Christ W; Lira-Junior R; Wirth L; Tauriainen J; Maleki K; Vanoni G; Vaheri A; Makela S; Mustonen J; Nordgren J; Smed-Sorensen A; Strandin T; Mjosberg J; Klingstrom J
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2024;54(4):e2350660Stamper CT; Marchalot A; Tibbitt CA; Weigel W; Jangard M; Theorell J; Mjosberg J
- Article: NATURE COMMUNICATIONS. 2024;15(1):1752Kvedaraite E; Lourda M; Mouratidou N; Duking T; Padhi A; Moll K; Czarnewski P; Sinha I; Xagoraris I; Kokkinou E; Damdimopoulos A; Weigel W; Hartwig O; Santos TE; Soini T; Van Acker A; Rahkonen N; Tullberg MF; Ringqvist E; Buggert M; Jorns C; Lindforss U; Nordenvall C; Stamper CT; Unnersjoe-Jess D; Akber M; Nadisauskaite R; Jansson J; Vandamme N; Sorini C; Grundeken ME; Rolandsdotter H; Rassidakis G; Villablanca EJ; Idestroem M; Eulitz S; Arnell H; Mjoesberg J; Henter J-I; Svensson M
- Article: NATURE COMMUNICATIONS. 2024;15(1):683Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunityDean I; Lee CYC; Tuong ZK; Li Z; Tibbitt CA; Willis C; Gaspal F; Kennedy BC; Matei-Rascu V; Fiancette R; Nordenvall C; Lindforss U; Baker SM; Stockmann C; Sexl V; Hammond SA; Dovedi SJ; Mjoesberg J; Hepworth MR; Carlesso G; Clatworthy MR; Withers DR
- Article: CELL REPORTS. 2023;42(11):113425Tacho-Pinot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin I-H; Dent A; Harada Y; Finlay C; Mjosberg J; Withers DR; Hepworth MR
- Journal article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143(11):s357Hoffer E; Zheng W; Beatrice Z; Sortebech D; Agerholm-Nielsen R; Zhang C; Schønfeldt T; Trselic T; Papavasileiou S; Kärner J; Ehrström M; Gahm J; Mjösberg J; Lysell J; Ødum N; Bryceson Y; Brunner P; Gerlach C; Eidsmo L
- Article: ALLERGY. 2023;78(9):2533-2536Björkander S; Maier P; Kere M; Merid SK; Wirth L; Wiegel W; Ekström S; Kull I; Bergström A; Melén E; Mjösberg J; Tibbitt CA
- Article: IMMUNITY. 2023;56(6):1285-1302.e7Zitti B; Hoffer E; Zheng W; Pandey RV; Schlums H; Casoni GP; Fusi I; Nguyen L; Karner J; Kokkinou E; Carrasco A; Gahm J; Ehrstrom M; Happaniemi S; Keita AV; Hedin CRH; Mjosberg J; Eidsmo L; Bryceson YT
- Article: CELL REPORTS MEDICINE. 2023;4(5):101038Kokkinou E; Soini T; Pandey RV; van Acker A; Theorell J; Czarnewski P; Kvedaraite E; Vandamme N; Lourda M; Sorini C; Weigel W; Carrasco A; Tibbitt CA; Schlums H; Lindforss U; Nordenvall C; Ljunggren M; Idestrom M; Svensson M; Henter J-I; Villablanca EJ; Bryceson YT; Rolandsdotter H; Mjosberg J
- Article: LANCET REGIONAL HEALTH-EUROPE. 2023;28:100608Yu Z; Ekstrom S; Bellander T; Ljungman P; Pershagen G; Eneroth K; Kull I; Bergstrom A; Georgelis A; Stafoggia M; Gruzieva O; Melen E
- Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1151754Ronnberg E; Ravindran A; Mazzurana L; Gong Y; Safholm J; Lorent J; Dethlefsen O; Orre A-C; Al-Ameri M; Adner M; Dahlen S-E; Dahlin JS; Mjosberg J; Nilsson G
- Article: CLINICAL AND TRANSLATIONAL ALLERGY. 2023;13(3):e12238Björkander S; Klevebro S; Hernandez-Pacheco N; Kere M; Ekström S; Sparreman Mikus M; van Hage M; James A; Kull I; Bergström A; Mjösberg J; Tibbitt CA; Melén E
- Article: RESPIRATORY RESEARCH. 2023;24(1):62Palma Medina LM; Babacic H; Dzidic M; Parke A; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgard J; Moll K; Michaelsson J; Flodstrom-Tullberg M; Brighenti S; Buggert M; Mjosberg J; Malmberg K-JK; Sandberg J; Gredmark-Russ S; Rooyackers O; Svensson MJ; Chambers BI; Eriksson L; Pernemalm MK; Bjorkstrom N; Aleman S; Ljunggren H-G; Klingstrom J; Stralin K; Norrby-Teglund A
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(1):e13195Ljunggren H-G; Heggernes Ask E; Cornillet Jeannin M; Strunz B; Chen P; Rao Muvva J; Akber M; Buggert M; Chambers BJ; Cuapio Gomez A; Dzidic M; Filipovic I; Flodstrom-Tullberg M; Garcia M; Gorin J-B; Gredmark-Russ S; Hertwig L; Klingstrom J; Kokkinou E; Kvedaraite E; Lourda M; Mjosberg J; Maucourant C; Norrby-Teglund A; Palma Medina LM; Parrot T; Perez-Potti A; Ponzetta A; Ringqvist E; Rivera-Ballesteros O; Rooyackers O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; Wullimann D; Eriksson LI; Aleman S; Malmberg K-J; Stralin K; Bjorkstrom NK
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: GLOBAL. 2022;1(2):37-42Mogensen I; Hallberg J; Bjorkander S; Du L; Zuo F; Hammarstrom L; Pan-Hammarstrom Q; Ekstrom S; Georgelis A; Palmberg L; Janson C; Bergstrom A; Melen E; Kull I
- Article: SCIENCE IMMUNOLOGY. 2022;7(70):eabj8301Kokkinou E; Pandey RV; Mazzurana L; Gutierrez-Perez I; Tibbitt CA; Weigel W; Soini T; Carrasco A; Rao A; Nagasawa M; Bal SM; Jangard M; Friberg D; Lindforss U; Nordenvall C; Ljunggren M; Haapaniemi S; Keita AV; Soderholm J; Hedin C; Spits H; Bryceson YT; Mjosberg J
- Article: JAMA NETWORK OPEN. 2022;5(4):e228109Yu Z; Bellander T; Bergstrom A; Dillner J; Eneroth K; Engardt M; Georgelis A; Kull I; Ljungman P; Pershagen G; Stafoggia M; Melen E; Gruzieva O
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2022;52(3):503-510Cornillet M; Strunz B; Rooyackers O; Ponzetta A; Chen P; Muvva JR; Akber M; Buggert M; Chambers BJ; Dzidic M; Filipovic I; Gorin J-B; Gredmark-Russ S; Hertwig L; Klingstrom J; Kokkinou E; Kvedaraite E; Lourda M; Mjosberg J; Maucourant C; Norrby-Teglund A; Parrot T; Perez-Potti A; Rivera-Ballesteros O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; Eriksson LI; Aleman S; Stralin K; Ljunggren H-G; Bjorkstrom NK
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(1):65-75.e8Bjorkander S; Du L; Zuo F; Ekstrom S; Wang Y; Wan H; Sherina N; Schoutens L; Andrell J; Andersson N; Georgelis A; Bergstrom A; Marcotte H; Kull I; Hammarstrom L; Melen E; Pan-Hammarstrom Q
- Article: FRONTIERS IN IMMUNOLOGY. 2021;12:674080Carrasco A; Sjoelander I; Van Acker A; Dernstedt A; Fehrm J; Forsell M; Friberg D; Mjoesberg J; Rao A
- Article: SCIENCE IMMUNOLOGY. 2021;6(64):eabk0894Niessl J; Sekine T; Lange J; Konya V; Forkel M; Maric J; Rao A; Mazzurana L; Kokkinou E; Weigel W; Llewellyn-Lacey S; Hodcroft EB; Karlsson AC; Fehrm J; Sundman J; Price DA; Mjosberg J; Friberg D; Buggert M
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(40):e2109123118Lourda M; Dzidic M; Hertwig L; Bergsten H; Medina LMP; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin J-B; Cornillet M; Emgard J; Moll K; Garcia M; Maleki KT; Klingstrom J; Michaelsson J; Flodstrom-Tullberg M; Brighenti S; Buggert M; Mjosberg J; Malmberg K-J; Sandberg JK; Henter J-I; Folkesson E; Gredmark-Russ S; Sonnerborg A; Eriksson LI; Rooyackers O; Aleman S; Stralin K; Ljunggren H-G; Bjorkstrom NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ
- Article: INFLAMMATORY BOWEL DISEASES. 2021;27(7):1128-1138Mazzurana L; Bonfiglio F; Forkel M; D'Amato M; Halfvarson J; Mjosberg J
- Article: CELL RESEARCH. 2021;31(5):554-568Mazzurana L; Czarnewski P; Jonsson V; Wigge L; Ringner M; Williams TC; Ravindran A; Bjorklund AK; Safholm J; Nilsson G; Dahlen S-E; Orre A-C; Al-Ameri M; Hoog C; Hedin C; Szczegielniak S; Almer S; Mjosberg J
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(6):e2018587118Kvedaraite E; Hertwig L; Sinha I; Ponzetta A; Myrberg IH; Lourda M; Dzidic M; Akber M; Klingstrom J; Folkesson E; Muvva JR; Chen P; Gredmark-Russ S; Brighenti S; Norrby-Teglund A; Eriksson LI; Rooyackers O; Aleman S; Stralin K; Ljunggren H-G; Ginhoux F; Bjorkstrom NK; Henter J-I; Svensson M
- Article: FRONTIERS IN IMMUNOLOGY. 2021;11:599647Dernstedt A; Leidig J; Holm A; Kerkman PF; Mjosberg J; Ahlm C; Henriksson J; Hultdin M; Forsell MNE
- Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1306Sandberg JT; Varnaite R; Christ W; Chen P; Muvva JR; Maleki KT; Garcia M; Dzidic M; Folkesson E; Skagerberg M; Ahlen G; Frelin L; Sallberg M; Eriksson LI; Rooyackers O; Sonnerborg A; Buggert M; Bjorkstrom NK; Aleman S; Stralin K; Klingstrom J; Ljunggren H-G; Blom K; Gredmark-Russ S
- Article: CELL. 2020;183(1):158-168.e14Sekine T; Perez-Potti A; Rivera-Ballesteros O; Stralin K; Gorin J-B; Olsson A; Llewellyn-Lacey S; Kamal H; Bogdanovic G; Muschiol S; Wullimann DJ; Kammann T; Emgard J; Parrot T; Folkesson E; Rooyackers O; Eriksson LI; Henter J-I; Sonnerborg A; Allander T; Albert J; Nielsen M; Klingstrom J; Gredmark-Russ S; Bjorkstrom NK; Sandberg JK; Price DA; Ljunggren H-G; Aleman S; Buggert M
- Article: SCIENCE IMMUNOLOGY. 2020;5(51):eabe1670Parrot T; Gorin J-B; Ponzetta A; Maleki KT; Kammann T; Emgard J; Perez-Potti A; Sekine T; Rivera-Ballesteros O; Gredmark-Russ S; Rooyackers O; Folkesson E; Eriksson LI; Norrby-Teglund A; Ljunggren H-G; Bjorkstrom NK; Aleman S; Buggert M; Klingstrom J; Stralin K; Sandberg JK
- Article: SCIENCE IMMUNOLOGY. 2020;5(50):eabd6832Maucourant C; Filipovic I; Ponzetta A; Aleman S; Cornillet M; Hertwig L; Strunz B; Lentini A; Reinius B; Brownlie D; Cuapio A; Ask EH; Hull RM; Haroun-Izquierdo A; Schaffer M; Klingstrom J; Folkesson E; Buggert M; Sandberg JK; Eriksson LI; Rooyackers O; Ljunggren H-G; Malmberg K-J; Michaelsson J; Marquardt N; Hammer Q; Stralin K; Bjorkstrom NK
- Article: NATURE COMMUNICATIONS. 2020;11(1):2049Rao A; Strauss O; Kokkinou E; Bruchard M; Tripathi KP; Schlums H; Carrasco A; Mazzurana L; Konya V; Villablanca EJ; Bjorkstrom NK; Lindforss U; Spits H; Mjosberg J
- Journal article: JOURNAL OF CROHNS & COLITIS. 2020;14(Supplement_1):s172Garcia AC; Rao A; Kokkinou E; Haapaniemi S; Lindforss U; Winberg ME; Casado-Bedmar M; Fenton T; Jørgensen P; Nordenvall C; Agace W; Keita ÅV; Söderholm JD; Mjösberg J
- Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2020;9(12):e1224Garcia M; Kokkinou E; Carrasco Garcia A; Parrot T; Palma Medina LM; Maleki KT; Christ W; Varnaite R; Filipovic I; Ljunggren H-G; Bjorkstrom NK; Folkesson E; Rooyackers O; Eriksson LI; Sonnerborg A; Aleman S; Stralin K; Gredmark-Russ S; Klingstrom J; Mjosberg J
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(10):1457-1973Cossarizza A; Chang H-D; Radbruch A; Acs A; Adam D; Adam-Klages S; Agace WW; Aghaeepour N; Akdis M; Allez M; Almeida LN; Alvisi G; Anderson G; Andrae I; Annunziato F; Anselmo A; Bacher P; Baldari CT; Bari S; Barnaba V; Barros-Martins J; Battistini L; Bauer W; Baumgart S; Baumgarth N; Baumjohann D; Baying B; Bebawy M; Becher B; Beisker W; Benes V; Beyaert R; Blanco A; Boardman DA; Bogdan C; Borger JG; Borsellino G; Boulais PE; Bradford JA; Brenner D; Brinkman RR; Brooks AES; Busch DH; Buescher M; Bushnell TP; Calzetti F; Cameron G; Cammarata I; Cao X; Cardell SL; Casola S; Cassatella MA; Cavani A; Celada A; Chatenoud L; Chattopadhyay PK; Chow S; Christakou E; Cicin-Sain L; Clerici M; Colombo FS; Cook L; Cooke A; Cooper AM; Corbett AJ; Cosma A; Cosmi L; Coulie PG; Cumano A; Cvetkovic L; Dang VD; Dang-Heine C; Davey MS; Davies D; De Biasi S; Del Zotto G; Dela Cruz GV; Delacher M; Della Bella S; Dellabona P; Deniz G; Dessing M; Di Santo JP; Diefenbach A; Dieli F; Dolf A; Doerner T; Dress RJ; Dudziak D; Dustin M; Dutertre C-A; Ebner F; Eckle SBG; Edinger M; Eede P; Ehrhardt GRA; Eich M; Engel P; Engelhardt B; Erdei A; Esser C; Everts B; Evrard M; Falk CS; Fehniger TA; Felipo-Benavent M; Ferry H; Feuerer M; Filby A; Filkor K; Fillatreau S; Follo M; Foerster I; Foster J; Foulds GA; Frehse B; Frenette PS; Frischbutter S; Fritzsche W; Galbraith DW; Gangaev A; Garbi N; Gaudilliere B; Gazzinelli RT; Geginat J; Gerner W; Gherardin NA; Ghoreschi K; Gibellini L; Ginhoux F; Goda K; Godfrey DI; Goettlinger C; Gonzalez-Navajas JM; Goodyear CS; Gori A; Grogan JL; Grummitt D; Gruetzkau A; Haftmann C; Hahn J; Hammad H; Haemmerling G; Hansmann L; Hansson G; Harpur CM; Hartmann S; Hauser A; Hauser AE; Haviland DL; Hedley D; Hernandez DC; Herrera G; Herrmann M; Hess C; Hoefer T; Hoffmann P; Hogquist K; Holland T; Hollt T; Holmdahl R; Hombrink P; Houston JP; Hoyer BF; Huang B; Huang F-P; Huber JE; Huehn J; Hundemer M; Hunter CA; Hwang WYK; Iannone A; Ingelfinger F; Ivison SM; Jaeck H-M; Jani PK; Javega B; Jonjic S; Kaiser T; Kalina T; Kamradt T; Kaufmann SHE; Keller B; Ketelaars SLC; Khalilnezhad A; Khan S; Kisielow J; Klenerman P; Knopf J; Koay H-F; Kobow K; Kolls JK; Kong WT; Kopf M; Korn T; Kriegsmann K; Kristyanto H; Kroneis T; Krueger A; Kuehne J; Kukat C; Kunkel D; Kunze-Schumacher H; Kurosaki T; Kurts C; Kvistborg P; Kwok I; Landry J; Lantz O; Lanuti P; LaRosa F; Lehuen A; LeibundGut-Landmann S; Leipold MD; Leung LYT; Levings MK; Lino AC; Liotta F; Litwin V; Liu Y; Ljunggren H-G; Lohoff M; Lombardi G; Lopez L; Lopez-Botet M; Lovett-Racke AE; Lubberts E; Luche H; Ludewig B; Lugli E; Lunemann S; Maecker HT; Maggi L; Maguire O; Mair F; Mair KH; Mantovani A; Manz RA; Marshall AJ; Martinez-Romero A; Martrus G; Marventano I; Maslinski W; Matarese G; Mattioli AV; Maueroder C; Mazzoni A; McCluskey J; McGrath M; McGuire HM; McInnes IB; Mei HE; Melchers F; Melzer S; Mielenz D; Miller SD; Mills KHG; Minderman H; Mjosberg J; Moore J; Moran B; Moretta L; Mosmann TR; Mueller S; Multhoff G; Munoz LE; Munz C; Nakayama T; Nasi M; Neumann K; Ng LG; Niedobitek A; Nourshargh S; Nunez G; O'Connor J-E; Ochel A; Oja A; Ordonez D; Orfao A; Orlowski-Oliver E; Ouyang W; Oxenius A; Palankar R; Panse I; Pattanapanyasat K; Paulsen M; Pavlinic D; Penter L; Peterson P; Peth C; Petriz J; Piancone F; Pickl WF; Piconese S; Pinti M; Pockley AG; Podolska MJ; Poon Z; Pracht K; Prinz I; Pucillo CEM; Quataert SA; Quatrini L; Quinn KM; Radbruch H; Radstake TRDJ; Rahmig S; Rahn H-P; Rajwa B; Ravichandran G; Raz Y; Rebhahn JA; Recktenwald D; Reimer D; Reis e Sousa C; Remmerswaal EBM; Richter L; Rico LG; Riddell A; Rieger AM; Robinson JP; Romagnani C; Rubartelli A; Ruland J; Saalmueller A; Saeys Y; Saito T; Sakaguchi S; Sala-de-Oyanguren F; Samstag Y; Sanderson S; Sandrock I; Santoni A; Sanz RB; Saresella M; Sautes-Fridman C; Sawitzki B; Schadt L; Scheffold A; Scherer HU; Schiemann M; Schildberg FA; Schimisky E; Schlitzer A; Schlosser J; Schmid S; Schmitt S; Schober K; Schraivogel D; Schuh W; Schueler T; Schulte R; Schulz AR; Schulz SR; Scotta C; Scott-Algara D; Sester DP; Shankey TV; Silva-Santos B; Simon AK; Sitnik KM; Sozzani S; Speiser DE; Spidlen J; Stahlberg A; Stall AM; Stanley N; Stark R; Stehle C; Steinmetz T; Stockinger H; Takahama Y; Takeda K; Tan L; Tarnok A; Tiegs G; Toldi G; Tornack J; Traggiai E; Trebak M; Tree TIM; Trotter J; Trowsdale J; Tsoumakidou M; Ulrich H; Urbanczyk S; van de Veen W; van den Broek M; van der Pol E; Van Gassen S; Van Isterdael G; van Lier RAW; Veldhoen M; Vento-Asturias S; Vieira P; Voehringer D; Volk H-D; von Borstel A; von Volkmann K; Waisman A; Walker RV; Wallace PK; Wang SA; Wang XM; Ward MD; Ward-Hartstonge KA; Warnatz K; Warnes G; Warth S; Waskow C; Watson JV; Watzl C; Wegener L; Weisenburger T; Wiedemann A; Wienands J; Wilharm A; Wilkinson RJ; Willimsky G; Wing JB; Winkelmann R; Winkler TH; Wirz OF; Wong A; Wurst P; Yang JHM; Yang J; Yazdanbakhsh M; Yu L; Yue A; Zhang H; Zhao Y; Ziegler SM; Zielinski C; Zimmermann J; Zychlinsky A
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(9):1344-1355Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Hoog C; Friberg D; Mjosberg J
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;144(1):61-69.e7Winkler C; Hochdoerfer T; Israelsson E; Hasselberg A; Cavallin A; Thoern K; Muthas D; Shojaee S; Lueer K; Mueller M; Mjoesberg J; Vaarala O; Hohlfeld J; Pardali K
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;143(6):2190-2201.e9Morita H; Kubo T; Ruckert B; Ravindran A; Soyka MB; Rinaldi AO; Sugita K; Wawrzyniak M; Wawrzyniak P; Motomura K; Tamari M; Orimo K; Okada N; Arae K; Saito K; Altunbulakli C; Castro-Giner F; Tan G; Neumann A; Sudo K; O'Mahony L; Honda K; Nakae S; Saito H; Mjosberg J; Nilsson G; Matsumoto K; Akdis M; Akdis CA
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;143(6):2202-2214.e5Maric J; Ravindran A; Mazzurana L; Van Acker A; Rao A; Kokkinou E; Ekoff M; Thomas D; Fauland A; Nilsson G; Wheelock CE; Dahlen S-E; Ferreiros N; Geisslinger G; Friberg D; Heinemann A; Konya V; Mjosberg J
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(6):884-893Hochdorfer T; Winkler C; Pardali K; Mjosberg J
- Journal article: JOURNAL OF IMMUNOLOGY. 2019;202(1_Supplement):65.6Heterogeneity in differentiation capacity among ILC precursors in human peripheral blood and tissuesKokkinou E; Gutierrez-Perez I; Pandey RV; Rao A; Mazzurana L; Almer S; Höög C; Lindforss U; Bryceson Y; Mjösberg J
- Journal article: JOURNAL OF IMMUNOLOGY. 2019;202(1_Supplement):187.10Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2019;294(15):6027-6041Coorens M; Rao A; Grafe SK; Unelius D; Lindforss U; Agerberth B; Mjosberg J; Bergman P
- Article: JOURNAL OF CROHNS & COLITIS. 2019;13(1):67-78Forkel M; van Tol S; Hoog C; Michaelsson J; Almer S; Mjosberg J
- Article: FRONTIERS IN IMMUNOLOGY. 2018;9:2193Ravindran A; Ronnberg E; Dahlin JS; Mazzurana L; Safholm J; Orre A-C; Al-Ameri M; Peachell P; Adner M; Dahlen S-E; Mjosberg J; Nilsson G
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2018;141(5):1761-1773.e6Maric J; Ravindran A; Mazzurana L; Bjorklund AK; Van Acker A; Rao A; Friberg D; Dahlen S-E; Heinemann A; Konya V; Mjosberg J
- Journal article: JOURNAL OF CROHNS & COLITIS. 2018;12(supplement_1):s119-s120Van Acker A; Kvedaraite E; Lourda M; Ideström M; Henter J-I; Svensson M; Mjösberg J
- Article: SCIENTIFIC REPORTS. 2018;8(1):154Parigi SM; Czarnewski P; Das S; Steeg C; Brockmann L; Fernandez-Gaitero S; Yman V; Forkel M; Hoog C; Mjosberg J; Westerberg L; Farnert A; Huber S; Jacobs T; Villablanca EJ
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2018;141(1):279-292Konya V; Czarnewski P; Forkel M; Rao A; Kokkinou E; Villablanca EJ; Almer S; Lindforss U; Friberg D; Hoeoeg C; Bergman P; Mjoesberg J
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2017;47(10):1584-1797Cossarizza A; Chang H-D; Radbruch A; Akdis M; Andrae I; Annunziato F; Bacher P; Barnaba V; Battistini L; Bauer WM; Baumgart S; Becher B; Beisker W; Berek C; Blanco A; Borsellino G; Boulais PE; Brinkman RR; Buescher M; Busch DH; Bushnell TP; Cao X; Cavani A; Chattopadhyay PK; Cheng Q; Chow S; Clerici M; Cooke A; Cosma A; Cosmi L; Cumano A; Dang VD; Davies D; De Biasi S; Del Zotto G; Della Bella S; Dellabona P; Deniz G; Dessing M; Diefenbach A; Di Santo J; Dieli F; Dolf A; Donnenberg VS; Doerner T; Ehrhardt GRA; Endl E; Engel P; Engelhardt B; Esser C; Everts B; Dreher A; Falk CS; Fehniger TA; Filby A; Fillatreau S; Follo M; Foerster I; Foster J; Foulds GA; Frenette PS; Galbraith D; Garbi N; Dolores Garcia-Godoy M; Geginat J; Ghoreschi K; Gibellini L; Goettlinger C; Goodyear CS; Gori A; Grogan J; Gross M; Gruetzkau A; Grummitt D; Hahn J; Hammer Q; Hauser AE; Haviland DL; Hedley D; Herrera G; Herrmann M; Hiepe F; Holland T; Hombrink P; Houston JP; Hoyer BF; Huang B; Hunter CA; Iannone A; Jaeck H-M; Javega B; Jonjic S; Juelke K; Jung S; Kaiser T; Kalina T; Keller B; Khan S; Kienhoefer D; Kroneis T; Kunkel D; Kurts C; Kvistborg P; Lannigan J; Lantz O; Larbi A; LeibundGut-Landmann S; Leipold MD; Levings MK; Litwin V; Liu Y; Lohoff M; Lombardi G; Lopez L; Lovett-Racke A; Lubberts E; Ludewig B; Lugli E; Maecker HT; Martrus G; Matarese G; Maueroeder C; McGrath M; McInnes I; Mei HE; Melchers F; Melzer S; Mielenz D; Mills K; Mirrer D; Mjosberg J; Moore J; Moran B; Moretta A; Moretta L; Mosmann TR; Mueller S; Muller W; Munz C; Multhoff G; Munoz LE; Murphy KM; Nakayama T; Nasi M; Neudoerfl C; Nolan J; Nourshargh S; O'Connor J-E; Ouyang W; Oxenius A; Palankar R; Panse I; Peterson P; Peth C; Petriz J; Philips D; Pickl W; Piconese S; Pinti M; Pockley AG; Podolska MJ; Pucillo C; Quataert SA; Radstake TRDJ; Rajwa B; Rebhahn JA; Recktenwald D; Remmerswaal EBM; Rezvani K; Rico LG; Robinson JP; Romagnani C; Rubartelli A; Ruckert B; Ruland J; Sakaguchi S; Sala-de-Oyanguren F; Samstag Y; Sanderson S; Sawitzki B; Scheffold A; Schiemann M; Schildberg F; Schimisky E; Schmid SA; Schmitt S; Schober K; Schueler T; Schulz AR; Schumacher T; Scotta C; Shankey TV; Shemer A; Simon A-K; Spidlen J; Stall AM; Stark R; Stehle C; Stein M; Steinmetz T; Stockinger H; Takahama Y; Tarnok A; Tian Z; Toldi G; Tornack J; Traggiai E; Trotter J; Ulrich H; van der Braber M; van Lier RAW; Veldhoen M; Vento-Asturias S; Vieira P; Voehringer D; Volk H-D; von Volkmann K; Waisman A; Walker R; Ward MD; Warnatz K; Warth S; Watson JV; Watzl C; Wegener L; Wiedemann A; Wienands J; Willimsky G; Wing J; Wurst P; Yu L; Yue A; Zhang Q; Zhao Y; Ziegler S; Zimmermann J
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2017;47(8):1280-1294Forkel M; Berglin L; Kekalainen E; Carlsson A; Svedin E; Michaelsson J; Nagasawa M; Erjefalt JS; Mori M; Flodstrom-Tullberg M; Bergquist A; Ljunggren H-G; Westgren M; Lindforss U; Friberg D; Jorns C; Ellis E; Bjorkstrom NK; Mjosberg J
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;139(4):1321-1330.e4Marquardt N; Kekalainen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjosberg J; Berglin L; Safholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre A-C; Svensson M; Dahlen B; Dahlen S-E; Ljunggren H-G; Michaelsson J
- Article: IMMUNITY. 2017;46(2):287-300Cheuk S; Schlums H; Serezal IG; Martini E; Chiang SC; Marquardt N; Gibbs A; Detlofsson E; Introini A; Forkel M; Hoog C; Tjernlund A; Michaelsson J; Folkersen L; Mjosberg J; Blomqvist L; Ehrstrom M; Stahle M; Bryceson YT; Eidsmo L
- Article: CELL REPORTS. 2017;18(7):1761-1773Shikhagaie MM; Bjorklund AK; Mjosberg J; Erjefalt JS; Cornelissen AS; Ros XR; Bal SM; Koning JJ; Mebius RE; Mori M; Bruchard M; Blom B; Spits H
- Article: PLOS ONE. 2016;11(12):e0168276Assadi G; Vesterlund L; Bonfiglio F; Mazzurana L; Cordeddu L; Schepis D; Mjosberg J; Ruhrmann S; Fabbri A; Vukojevic V; Percipalle P; Salomons FA; Laurencikiene J; Torkvist L; Halfvarson J; D'Amato M
- Article: INFLAMMATORY BOWEL DISEASES. 2016;22(12):2788-2793Ando Y; Mazzurana L; Forkel M; Okazaki K; Aoi M; Schmidt PT; Mjosberg J; Bresso F
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2016;138(5):1265-1276Mjosberg J; Spits H
- Article: IMMUNOLOGY LETTERS. 2016;179:36-42Konya V; Mjosberg J
- Article: JOURNAL OF IMMUNOLOGY. 2016;197(8):3069-3075Marquardt N; Ivarsson MA; Sundstrom E; Akesson E; Martini E; Eidsmo L; Mjosberg J; Friberg D; Kublickas M; Ek S; Tegerstedt G; Seiger A; Westgren M; Michaelsson J
- Article: GUT. 2016;65(10):1632-1641Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBDKvedaraite E; Lourda M; Idestrom M; Chen P; Olsson-Akefeldt S; Forkel M; Gavhed D; Lindforss U; Mjosberg J; Henter J-I; Svensson M
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2016;115:67Boij R; Mjosberg J; Arvelund-Svensson J; Hjort M; Berg G; Matthiesen L; Jenmalm M; Ernerudh J
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2016;115:29Boij R; Mjosberg J; Arvelund-Svensson J; Hjort M; Berg G; Matthiesen L; Jenmalm M; Ernerudh J
- Article: NATURE IMMUNOLOGY. 2016;17(4):451-460Bjorklund AK; Forkel M; Picelli S; Konya V; Theorell J; Friberg D; Sandberg R; Mjosberg J
- Article: IMMUNITY. 2016;44(2):391-405Kloverpris HN; Kazer SW; Mjosberg J; Mabuka JM; Wellmann A; Ndhlovu Z; Yadon MC; Nhamoyebonde S; Muenchhoff M; Simoni Y; Andersson F; Kuhn W; Garrett N; Burgers WA; Kamya P; Pretorius K; Dong K; Moodley A; Newell EW; Kasprowicz V; Karim SSA; Goulder P; Shalek AK; Walker BD; Ndung'u T; Leslie A
- Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2015;74(4):368-378Boij R; Mjosberg J; Svensson-Arvelund J; Hjorth M; Berg G; Matthiesen L; Jenmalm MC; Ernerudh J
- Article: JOURNAL OF IMMUNOLOGY. 2015;194(6):2467-2471Marquardt N; Beziat V; Nystrom S; Hengst J; Ivarsson MA; Kekalainen E; Johansson H; Mjosberg J; Westgren M; Lankisch TO; Wedemeyer H; Ellis EC; Ljunggren H-G; Michaelsson J; Bjorkstrom NK
- Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134(9):2351-2360Teunissen MBM; Munneke JM; Bernink JH; Spuls PI; Res PCM; te Velde A; Cheuk S; Brouwer MWD; Menting SP; Eidsmo L; Spits H; Hazenberg MD; Mjosberg J
- Article: BLOOD. 2014;124(5):812-821Munneke JM; Bjorklund AT; Mjosberg JM; Garming-Legert K; Bernink JH; Blom B; Huisman C; van Oers MHJ; Spits H; Malmberg K-J; Hazenberg MD
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2014;133(4):1184-1194Xue L; Salimi M; Panse I; Mjosberg JM; McKenzie ANJ; Spits H; Klenerman P; Ogg G
- Article: IMMUNITY. 2013;39(3):622-622.e1Sonnenberg GF; Mjösberg J; Spits H; Artis D
- Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:a133Hreggvidsdottir HS; Mjosberg J; Bernink J; Baeten D; Spits H
- Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:a9Hreggvidsdottir HS; Mjösberg J; Bernink J; Baeten D; Spits H
- Article: NATURE IMMUNOLOGY. 2013;14(3):221-229Bernink JH; Peters CP; Munneke M; te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjosberg JM; Spits H
- Journal article: BLOOD. 2012;120(21):sci-19Spits H; Bernink J; Peters C; Mjosberg J
- Journal article: JOURNAL OF TRANSLATIONAL MEDICINE. 2012;10(Suppl 3):i16Spits H; Bernink J; Peters C; Mjosberg J
- Article: IMMUNITY. 2012;37(4):649-659Mjösberg J; Bernink J; Golebski K; Karrich JJ; Peters CP; Blom B; te Velde AA; Fokkens WJ; van Drunen CM; Spits H
- Article: FRONTIERS IN IMMUNOLOGY. 2012;3:72Hoorweg K; Peters CP; Cornelissen F; Aparicio-Domingo P; Papazian N; Kazemier G; Mjösberg JM; Spits H; Cupedo T
- Article: NATURE IMMUNOLOGY. 2011;12(11):1055-1062Mjösberg JM; Trifari S; Crellin NK; Peters CP; van Drunen CM; Piet B; Fokkens WJ; Cupedo T; Spits H
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2011;90(2):149Forsberg A; Straka E; Johansson E; Mehta R; Berg G; Jenmalm MC; Mjösberg J; Ernerudh J
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2011;90(2):131Ernerudh J; Forsberg A; Straka E; Johansson E; Mehta RB; Svensson J; Matthiesen L; Boij R; Berg G; Mjösberg J; Jenmalm MC
- Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2011;66 Suppl 1:31-43Ernerudh J; Berg G; Mjösberg J
- Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(1):57-66Edstrom M; Mellergard J; Mjosberg J; Jenmalm MC; Vrethem M; Press R; Dahle C; Ernerudh J
- Article: BIOLOGY OF REPRODUCTION. 2010;82(4):698-705Mjösberg J; Berg G; Jenmalm MC; Ernerudh J
- Article: BJU INTERNATIONAL. 2009;104(11):1758-1765Save S; Mjosberg J; Poljakovic M; Mohlin C; Persson K
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2009;81(2):147Mjösberg J; Jenmalm MC; Berg G; Ernerudh J
- Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2009;81(2):160-161Mjösberg J; Svensson J; Johansson E; Hellström L; Casas R; Jenmalm MC; Boij R; Matthiesen L; Jönsson J-I; Berg G; Ernerudh J
- Article: JOURNAL OF IMMUNOLOGY. 2009;183(1):759-769Mjösberg J; Svensson J; Johansson E; Hellström L; Casas R; Jenmalm MC; Boij R; Matthiesen L; Jönsson J-I; Berg G; Ernerudh J
- Article: PLOS ONE. 2008;3(4):e2078Gustafsson C; Mjösberg J; Matussek A; Geffers R; Matthiesen L; Berg G; Sharma S; Buer J; Ernerudh J
- Article: IMMUNOLOGY. 2007;120(4):456-466Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
- Visa fler
Alla övriga publikationer
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2024;54:1128Boulouis C; Mouchtaridi E; Muller TR; Mak JYW; Fairlie DP; Bergman P; Michaelsson J; Halfvarson J; Mjosberg J; Buggert M; Sandberg JK
- Editorial comment: CELL RESEARCH. 2024;34(6):403-404Spits H; Mjosberg J
- Preprint: BIORXIV. 2024Rødahl IE; Ivarsson MA; Loh L; Mold JE; Westgren M; Friberg D; Mjösberg J; Björkström NK; Marquardt N; Nixon DF; Michaëlsson J
- Conference publication: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2023;143(11):S357Hoffer E; Zheng W; Beatrice Z; Sortebech D; Agerholm-Nielsen R; Zhang C; Schonfeldt T; Trselic T; Papavasileiou S; Karner J; Ehrstrom M; Gahm J; Mjosberg J; Lysell J; Odum N; Bryceson Y; Brunner P; Gerlach C; Eidsmo L
- Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2023;62:pa4407Kere M; Bjorkander S; Tibbitt CA; Mjosberg J; Melen E
- Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2023;62:oa2502Bjorkander S; Maier P; Kere M; Merid SK; Wirth L; Weigel W; Mjosberg J; Melen E; Tibbitt C
- Meeting abstract: EUROPEAN RESPIRATORY JOURNAL. 2023;62:oa2495Wirth L; Yasinska V; Tibbitt CA; Weigel W; Hochdorfer T; Andersson LI; Sparreman-Mikus M; Dahlen B; Dahlen S-E; Mjosberg J
- Preprint: BIORXIV. 2023Dean I; Lee CYC; Tuong Z; Li Z; Tibbitt C; Willis C; Gaspal F; Kennedy B; Matei-Rascu V; Fiancette R; Nordenvall C; Lindforss U; Baker SM; Stockmann C; Sexl V; Carlesso G; Hammond S; Dovedi S; Mjösberg J; Hepworth M; Clatworthy M; Withers D
- Review: NATURE REVIEWS IMMUNOLOGY. 2022;22(11):701-712Spits H; Mjosberg J
- Preprint: MEDRXIV. 2022García M; García AC; Tauriainen J; Maleki K; Vaheri A; Mäkelä S; Mustonen J; Smed-Sörensen A; Strandin T; Mjösberg J; Klingström J
- Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(4):e13156Marchalot A; Mjosberg J
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:95Niessl J; Sekine T; Lange J; Konya V; Forkel M; Maric J; Rao A; Mazzurana L; Kokkinou E; Fehrm J; Sundman J; Price DA; Hodcroft EB; Neher RA; Mjosberg J; Friberg D; Buggert M
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:155Dernstedt A; Leidig J; Holm A; Kerkman PF; Mjosberg J; Ahlm C; Henriksson J; Hultdin M; Forsell MN
- Editorial comment: ALLERGY. 2021;76(6):1925-1928Mjosberg J; Roncarolo MG; Blom B
- Preprint: MEDRXIV. 2021Lourda M; Dzidic M; Hertwig L; Bergsten H; Medina LP; Kvedaraite E; Chen P; Muvva J; Gorin J-B; Cornillet M; Emgård J; Moll K; García M; Maleki K; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg J; Henter J-I; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson L; Rooyackers O; Aleman S; Strålin K; Ljunggren H-G; Björkström N; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers B; the Karolinska KI/K COVID-19 Study Group
- Preprint: MEDRXIV. 2020García M; Kokkinou E; García AC; Parrot T; Palma Medina L; Maleki K; Christ W; Varnaitė R; Filipovic I; Ljunggren H-G; Björkström N; Folkesson E; Rooyackers O; Eriksson L; Sönnerborg A; Aleman S; Strålin K; Gredmark-Russ S; Klingström J; Mjösberg J; the Karolinska KI/K COVID-19 Study Group
- Review: TRENDS IN IMMUNOLOGY. 2020;41(10):902-917Meininger I; Carrasco A; Rao A; Soini T; Kokkinou E; Mjosberg J
- Preprint: BIORXIV. 2020Dernstedt A; Leidig J; Holm A; Mjösberg J; Ahlm C; Henriksson J; Hultdin M; Forsell MN
- Conference publication: JOURNAL OF CROHNS & COLITIS. 2020;14:S172Garcia AC; Rao A; Kokkinou E; Haapaniemi S; Lindforss U; Winberg ME; Casado-Bedmar M; Fenton T; Jorgensen P; Nordenvall C; Agace W; Keita AV; Soderholm JD; Mjosberg J
- Book chapter: THE AUTOIMMUNE DISEASES. 2020;p. 229-242Bryceson YT; Björkström NK; Mjösberg J; Ljunggren H-G
- Conference publication: JOURNAL OF IMMUNOLOGY. 2019;202(1)Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Hoog C; Friberg D; Mjosberg J
- Conference publication: JOURNAL OF IMMUNOLOGY. 2019;202(1)Heterogeneity in differentiation capacity among ILC precursors in human peripheral blood and tissuesKokkinou E; Gutierrez-Perez I; Pandey RV; Rao A; Mazzurana L; Almer S; Hoog C; Lindforss U; Bryceson Y; Mjosberg J
- Review: SEMINARS IN IMMUNOPATHOLOGY. 2018;40(4):407-419Mazzurana L; Rao A; Van Acker A; Mjosberg J
- Review: ALLERGY. 2018;73(4):837-850Krohn IK; Shikhagaie MM; Golebski K; Bernink JH; Breynaert C; Creyns B; Diamant Z; Fokkens WJ; Gevaert P; Hellings P; Hendriks RW; Klimek L; Mjosberg J; Morita H; Ogg GS; O'Mahony L; Schwarze J; Seys SF; Shamji MH; Bal SM
- Conference publication: JOURNAL OF CROHNS & COLITIS. 2018;12:S119-S120Van Acker A; Kvedaraite E; Lourda M; Idestrom M; Henter J-I; Svensson M; Mjosberg J
- Editorial comment: SCIENCE. 2018;359(6371):36-37Mjosberg J; Rao A
- Conference publication: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2018;197Hochdorfer T; Winkler C; Mjosberg J; Pardali K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):300Avinash R; Hockerlind ER; Dahlin J; Bergman P; Orre A-C; Adner M; Safholm J; Dahlen S-E; Peachell P; Mjosberg J; Nilsson G
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):253Kvedaraite E; Lourda M; Van Acker A; Jess DU; Gavhed D; Mjosberg J; Idestrom M; Henter J-I; Svensson M
- Conference publication: SWISS MEDICAL WEEKLY. 2017;147:83SShikhagaie MM; Spits H; Blom B; Bjorklund AK; Mjosberg J
- Editorial comment: IMMUNITY. 2017;46(3):344-346Mjosberg J; Mazzurana L
- Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2016;31:172Ando Y; Mazzurana L; Forkel M; Okazaki K; Schmidt PT; Mjosberg J; Bresso F
- Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2016;16(10):73Forkel M; Mjosberg J
- Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:67-68Marquardt N; Kekalainen E; Wilson JN; Ivarsson MA; Mjosberg J; Safholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre A-C; Dahlen B; Dahlen S-E; Ljunggren H-G; Michaelsson J
- Conference publication: ALLERGY. 2016;71:25Maric J; Heinemann A; Konya V; Mjosberg J
- Corrigendum: NATURE IMMUNOLOGY. 2016;17(6):740Bjorklund AK; Forkel M; Picelli S; Konya V; Theorell J; Friberg D; Sandberg R; Mjosberg J
- Corrigendum: NATURE IMMUNOLOGY. 2016;17(4)Bjorklund AK; Forkel M; Picelli S; Konya V; Theorell J; Friberg D; Sandberg R; Mjosberg J
- Review: IMMUNOLOGY LETTERS. 2016;172:124-131Peters CP; Mjosberg JM; Bernink JH; Spits H
- Review: AMERICAN JOURNAL OF TRANSPLANTATION. 2015;15(11):2795-2801Konya V; Mjosberg J
- Conference publication: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2014;30:A14Kloverpris HN; Noorbhai A; Kuhn W; Yadon M; Ramsuran D; Nhamoyebonde S; Kasprowicz V; Walker B; Ndung'u T; Goulder P; Karim AS; Mjosberg J; Leslie A
- Review: CLINICAL AND EXPERIMENTAL ALLERGY. 2014;44(8):1033-1043Mjosberg J; Eidsmo L
- Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2014;134(1):228-230Forsberg A; Bengtsson M; Eringfalt A; Ernerudh J; Mjosberg J; Jenmalm MC
- Book chapter: THE AUTOIMMUNE DISEASES. 2014;p. 187-199Bryceson YT; Björkström NK; Mjösberg J; Ljunggren H-G
- Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S487-S488Hreggvidsdottir HS; Turina MC; Noordenbos T; Munneke M; Peters C; Bernink J; Mjosberg J; Baeten DL; Spits H
- Conference publication: ALLERGY. 2013;68:443Forsberg A; Bengtsson M; Eringfalt A; Ernerudh J; Mjosberg J; Jenmalm M
- Review: IMMUNOLOGY. 2013;139(4):416-427Bjorkstrom NK; Kekalainen E; Mjosberg J
- Review: IMMUNOLOGICAL REVIEWS. 2013;252(1):133-138Bernink J; Mjosberg J; Spits H
- Conference publication: BLOOD. 2012;120(21):4104Munneke JM; Mjosberg JM; Bernink JHJ; Huisman C; Spits H; Hazenberg MD
- Review: EUROPEAN JOURNAL OF IMMUNOLOGY. 2012;42(8):1916-1923Mjösberg J; Bernink J; Peters C; Spits H
- Editorial comment: EUROPEAN JOURNAL OF IMMUNOLOGY. 2012;42(5):1093-1096Mjösberg J; Spits H
- Review: CURRENT ALLERGY AND ASTHMA REPORTS. 2012;12(2):120-126van Drunen CM; Mjösberg JM; Segboer CL; Cornet ME; Fokkens WJ
- Editorial comment: IMMUNITY. 2012;36(1):5-7Spits H; Mjösberg J
- Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2008;203(2):131-132Edstrom M; Dahle C; Jenmalm M; Mellergard J; Mjosberg J; Press R; Vrethem M; Ernerudh J
- Visa fler
Forskningsbidrag
- Swedish Research Council1 January 2025 - 31 December 2029Biologics targeting type 2 cytokines offer new hope for patients with severe asthma, but not all patients respond, and none are cured. This calls for increased understanding of airway tissue type 2 lymphocytes and how they are regulated by biologics. Innate lymphoid cells type 2 (ILC2) and type 2 T cells (Th2 and Tc2), orchestrate type 2 inflammation. I will build on our unexpected finding that treatment with anti-interleukin (IL)-5 biologics causes an increase in circulating type 2 lymphocytes, implying biologics effects on lymphocyte trafficking, differentiation, and tissue residency. To test this hypothesis, I will capitalize on leading a clinical asthma research unit and immunology lab, enabling us to perform pioneering immunological studies using unique airway tissue samples from patients with severe asthma before and during biologics treatment. My translational team of clinical, immunological and computational researchers will determine the unique features of airway resident lymphocytes and the epigenetic and transcriptional effects of biologics on circulating and airway-resident lymphocytes. We will also dissect the mechanisms involved in lymphocyte trafficking and differentiation in the airways. This will increase the understanding of human airway lymphocyte diversification, trafficking, tissue residency and differentiation in relation to biologics treatment efficacy. Our studies will reveal new targets for treatment and means to better tailor the use of biologics.
- Swedish Cancer Society1 January 2023Inflammatory bowel disease (IBD) means an increased risk of developing colorectal cancer, which is thought to be caused by intestinal inflammation giving rise to cell changes and cancer. However, what role the intestinal immune system, mainly lymphocytes such as T cells and innate lymphocytes (ILCs), which I recently discovered in humans, play in this process is unclear. We intend to answer this question by collaborating with clinical researchers where we can perform advanced immunological analyzes of intestinal samples from patients with IBD and colorectal cancer, before and after therapy. We intend to study intestinal lymphocytes with single-cell techniques at both gene expression and protein level, which may reveal new subsets of lymphocytes but also differences between intestinal lymphocytes in the spectrum of healthy-inflamed-tumorous colon. Intestinal lymphocytes will then be analyzed in intestinal samples from IBD patients before and after treatment with new immunomodulatory treatments. Similarly, we will also analyze intestinal samples from patients with colorectal cancer that has spread to the abdominal cavity and are being treated with chemotherapy. Our in-depth analyzes will reveal intestinal lymphocytes that may contribute to inflammation and/or cancer development in the intestine. These studies will also reveal intestinal lymphocytes that may predict or mark response to immunomodulatory therapy in IBD, and chemotherapy in metastatic CRC. This is extremely important because the right choice of effective treatment saves both individual suffering and societal costs.
- European Research Council1 September 2020 - 31 August 2026Inflammatory bowel disease (IBD) constitutes an increasing global health burden, yet effective treatments are lacking. Hampering rationale treatment strategies, the human intestinal immune system remains largely unexplored. I have made seminal contributions to the discovery and characterization of innate lymphoid cells (ILCs) (Nat Immunol 2011, 2013 and 2016, Immunity 2012), revealing that in addition to antigen-specific adaptive T cells, innate equivalents play important roles in mucosal immunity. Determining the complementarity and redundancy of these two lymphocyte systems, acting in concert, is important for our understanding of inflammatory diseases and the development of novel therapies. For this proposal, I am in the beneficial position of having access to unique patient samples as well as established methods for single-cell RNA-sequencing to perform an ambitious and comprehensive molecular dissection of the human intestinal lymphocyte compartments in IBD. With this approach, I will determine parallels between known, and identify novel, subsets of tissue-resident, inflammation-associated, innate and adaptive lymphocytes. Building on this unprecedented molecular characterization, we will take on some of the most pressing clinical problems in IBD by performing longitudinal assessments of intestinal lymphocytes from IBD patients on conventional and biological treatments. As only a fraction of patients respond to treatment, this approach provides a golden opportunity to unveil immunological signatures of treatment response and drug-induced transformation of inflammation in non-responders. Furthermore, we will unfold critical disease mechanisms and reveal novel therapy targets and how they can be used to personalize treatment. In summary, my ambitious, yet feasible, proposal combines state-of-the-art technology with access to unique patient materials. My studies are likely to advance our understanding of the complex intestinal lymphocyte network in IBD.
- Swedish Cancer Society1 January 2020I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. ILCs are in many ways similar to T cells, whose function can be manipulated by immunotherapy in cancer, so-called check-point blockade. In mice, ILC, like T cells, plays an important role in intestinal inflammation and the development of colon cancer. However, this is unknown in humans. Furthermore, the relationship between ILC and T cells, the way these cells are regulated by the local environment in the tumor, and the way they affect tumor growth in colon cancer are hitherto unknown. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) and their relationship to T cells in colon cancer. My hypothesis is that these cells are regulated by the environment inside the tumor and also have an active role in controlling tumor growth. Through access to unique intestinal tissue samples, I can directly study ILC and T cells that are in the malignant tissue. I can determine in detail their function and thus determine what role these cells can play in colon cancer. My research will increase the understanding of the unique and complementary ways ILCs and T cells act in tumor immunity, and the way in which these cells are regulated by the tumor, but also control tumor growth in colon cancer. The purpose of my research is to find new therapy targets, associated with the interaction between cancer cells and ILC and T cells, that can be used to treat colon cancer.
- Tissue-specific regulation of human intratumoral innate and adaptive lymphocytes in colorectal cancerSwedish Cancer Society1 January 2019I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. ILCs are in many ways similar to T cells, whose function can be manipulated by immunotherapy in cancer, so-called check-point blockade. In mice, ILC, like T cells, plays an important role in intestinal inflammation and the development of colon cancer. However, this is unknown in humans. Furthermore, the relationship between ILC and T cells, the way these cells are regulated by the local environment in the tumor, and the way they affect tumor growth in colon cancer are hitherto unknown. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) and their relationship to T cells in colon cancer. My hypothesis is that these cells are regulated by the environment inside the tumor and also have an active role in controlling tumor growth. Through access to unique intestinal tissue samples, I can directly study ILC and T cells that are in the malignant tissue. I can determine in detail their function and thus determine what role these cells can play in colon cancer. My research will increase the understanding of the unique and complementary ways ILCs and T cells act in tumor immunity, and the way in which these cells are regulated by the tumor, but also control tumor growth in colon cancer. The purpose of my research is to find new therapy targets, associated with the interaction between cancer cells and ILC and T cells, that can be used to treat colon cancer.
- Swedish Research Council1 January 2019 - 31 December 2024
- Swedish Research Council1 January 2019Inflammatory bowel disease (IBD) constitutes an increasing global health burden. Hampering rationale treatment strategies, the human intestinal immune system remains largely unexplored. I have made seminal discoveries of innate lymphoid cells (ILC) (Nat Immunol 2011, 2013 and 2016, Immunity 2012), revealing that in addition to adaptive T cells, their innate equivalents, ILC, contribute to mucosal immunity. I am in the beneficial position of having access to unique patient samples as well as established methods for single-cell RNA-sequencing and epigenetic investigations (ATAC-seq) to perform a comprehensive molecular dissection of the human intestinal lymphocyte compartments in IBD. With this approach, we will determine functional and spatial parallels between known, and identify novel, subsets of tissue-resident, inflammation-associated, innate and adaptive lymphocytes (year 1-3). Building on this unprecedented molecular characterization, we will perform longitudinal assessments of intestinal lymphocytes from treated IBD patients (year 4-5). This approach provides a golden opportunity to unveil immunological signatures of treatment response, disease mechanisms and novel therapy targets. In summary, my ambitious, yet feasible, proposal combines state-of-the-art technology with access to unique patient materials. My established team will work closely together with clinicians and other scientists to advance our understanding of the complex intestinal lymphocyte network in IBD.
- Importance of the lymphoid cells of the innate immune system in inflammatory bowel disease and colon cancerSwedish Cancer Society1 January 2018Prolonged inflammatory bowel disease (IBD) represents a dramatically increased risk of colon cancer. It is likely that the chronic inflammation of IBD is a direct cause of colon cancer and therefore IBD can be seen as a precursor to cancer. I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. In mice, these cells have a very important role in intestinal inflammation and tumor development, but the specific link between the role of ILC in IBD and colon cancer in humans has not yet been investigated. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) in inflammatory bowel disease (IBD) and colon cancer. My hypothesis is that these cells are directly involved in the development of IBD and thereby colon cancer and also have an active role in regulating cancer growth. By accessing unique intestinal tissue samples, I can directly study the ILC contained in the inflamed or malignant tissue. I can in detail determine their function and thus determine what role these cells can play in IBD and colon cancer. My hypothesis is that congenital lymphoid cells (ILC) are extremely important actors in inflammatory bowel disease (IBD) and colon cancer. My research will increase understanding of this group of cells in general, and especially their role in IBD and colon cancer. IBD can be seen as a precursor to cancer. Thus, knowledge of IBD is extremely important in preventing the onset of colon cancer. The purpose of my research is to find new therapy goals associated with ILC, which can be used for prevention and treatment of IBD and colon cancer.
- Importance of the lymphoid cells of the innate immune system in inflammatory bowel disease and colon cancerSwedish Cancer Society1 January 2017Prolonged inflammatory bowel disease (IBD) represents a dramatically increased risk of colon cancer. It is likely that the chronic inflammation of IBD is a direct cause of colon cancer and therefore IBD can be seen as a precursor to cancer. I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. In mice, these cells have a very important role in intestinal inflammation and tumor development, but the specific link between the role of ILC in IBD and colon cancer in humans has not yet been investigated. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) in inflammatory bowel disease (IBD) and colon cancer. My hypothesis is that these cells are directly involved in the development of IBD and thereby colon cancer and also have an active role in regulating cancer growth. By accessing unique intestinal tissue samples, I can directly study the ILC contained in the inflamed or malignant tissue. I can in detail determine their function and thus determine what role these cells can play in IBD and colon cancer. My hypothesis is that congenital lymphoid cells (ILC) are extremely important actors in inflammatory bowel disease (IBD) and colon cancer. My research will increase understanding of this group of cells in general, and especially their role in IBD and colon cancer. IBD can be seen as a precursor to cancer. Thus, knowledge of IBD is extremely important in preventing the onset of colon cancer. The purpose of my research is to find new therapy goals associated with ILC, which can be used for prevention and treatment of IBD and colon cancer.
- Importance of the lymphoid cells of the innate immune system in inflammatory bowel disease and colon cancerSwedish Cancer Society1 January 2016Prolonged inflammatory bowel disease (IBD) represents a dramatically increased risk of colon cancer. It is likely that the chronic inflammation of IBD is a direct cause of colon cancer and therefore IBD can be seen as a precursor to cancer. I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. In mice, these cells have a very important role in intestinal inflammation and tumor development, but the specific link between the role of ILC in IBD and colon cancer in humans has not yet been investigated. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) in inflammatory bowel disease (IBD) and colon cancer. My hypothesis is that these cells are directly involved in the development of IBD and thereby colon cancer and also have an active role in regulating cancer growth. By accessing unique intestinal tissue samples, I can directly study the ILC contained in the inflamed or malignant tissue. I can in detail determine their function and thus determine what role these cells can play in IBD and colon cancer. My hypothesis is that congenital lymphoid cells (ILC) are extremely important actors in inflammatory bowel disease (IBD) and colon cancer. My research will increase understanding of this group of cells in general, and especially their role in IBD and colon cancer. IBD can be seen as a precursor to cancer. Thus, knowledge of IBD is extremely important in preventing the onset of colon cancer. The purpose of my research is to find new therapy goals associated with ILC, which can be used for prevention and treatment of IBD and colon cancer.
- Deutsche Forschungsgemeinschaft1 January 2016 - 31 December 2019
- Importance of the lymphoid cells of the innate immune system in inflammatory bowel disease and colon cancerSwedish Cancer Society1 January 2015Prolonged inflammatory bowel disease (IBD) represents a dramatically increased risk of colon cancer. It is likely that the chronic inflammation of IBD is a direct cause of colon cancer and therefore IBD can be seen as a precursor to cancer. I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. In mice, these cells have a very important role in intestinal inflammation and tumor development, but the specific link between the role of ILC in IBD and colon cancer in humans has not yet been investigated. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) in inflammatory bowel disease (IBD) and colon cancer. My hypothesis is that these cells are directly involved in the development of IBD and thereby colon cancer and also have an active role in regulating cancer growth. By accessing unique intestinal tissue samples, I can directly study the ILC contained in the inflamed or malignant tissue. I can in detail determine their function and thus determine what role these cells can play in IBD and colon cancer. My hypothesis is that congenital lymphoid cells (ILC) are extremely important actors in inflammatory bowel disease (IBD) and colon cancer. My research will increase understanding of this group of cells in general, and especially their role in IBD and colon cancer. IBD can be seen as a precursor to cancer. Thus, knowledge of IBD is extremely important in preventing the onset of colon cancer. The purpose of my research is to find new therapy goals associated with ILC, which can be used for prevention and treatment of IBD and colon cancer.
- Importance of the lymphoid cells of the innate immune system in inflammatory bowel disease and colon cancerSwedish Cancer Society1 January 2014Prolonged inflammatory bowel disease (IBD) represents a dramatically increased risk of colon cancer. It is likely that the chronic inflammation of IBD is a direct cause of colon cancer and therefore IBD can be seen as a precursor to cancer. I, along with several other research groups, have recently discovered a new cell family in the immune system. These are called "congenital lymphoid cells" (ILC) and are found in both mice and humans. In mice, these cells have a very important role in intestinal inflammation and tumor development, but the specific link between the role of ILC in IBD and colon cancer in humans has not yet been investigated. The purpose of my project is to investigate the role of congenital lymphoid cells (ILC) in inflammatory bowel disease (IBD) and colon cancer. My hypothesis is that these cells are directly involved in the development of IBD and thereby colon cancer and also have an active role in regulating cancer growth. By accessing unique intestinal tissue samples, I can directly study the ILC contained in the inflamed or malignant tissue. I can in detail determine their function and thus determine what role these cells can play in IBD and colon cancer. My hypothesis is that congenital lymphoid cells (ILC) are extremely important actors in inflammatory bowel disease (IBD) and colon cancer. My research will increase understanding of this group of cells in general, and especially their role in IBD and colon cancer. IBD can be seen as a precursor to cancer. Thus, knowledge of IBD is extremely important in preventing the onset of colon cancer. The purpose of my research is to find new therapy goals associated with ILC, which can be used for prevention and treatment of IBD and colon cancer.
- Swedish Research Council1 January 2014 - 31 December 2018
- Innate lymphoid cells in gut inflammation and cancerSwedish Foundation for Strategic Research1 September 2013 - 31 December 2016
- Swedish Research Council16 July 2012 - 31 May 2013
- FWF Austrian Science Fund1 March 2012 - 30 June 2021
- Recently discovered the role of congenital lymphoida cells in human inflammatory bowel diseaseSwedish Research Council1 January 2011 - 30 September 2012
Anställningar
- Professor, Medicin, Huddinge, Karolinska Institutet, 2022-
Examina och utbildning
- Docent, Immunologi, Karolinska Institutet, 2019